Cash Flow from Operating Activities (Quarterly)

Cash Flow from Operating Activities: A company's cash flows from operations.

Royalty Pharma PLC (RPRX) had Cash Flow from Operating Activities of $596.08M for the most recently reported fiscal quarter, ending 2025-03-31.

Quarterly Annual

Figures for fiscal quarter ending 2025-03-31

Income Statement Financials
Revenue	$568.25M
Net Income	$238.35M
Cost of Goods Sold	--
Gross Profit	$568.25M
Operating Expenses	$34.06M
Operating Income	$534.18M
Non-Operating Income/Expense	$-100.75M
Pre-Tax Income	$433.43M
Normalized Pre-Tax Income	$437.71M
Income after Taxes	$433.43M
Income from Continuous Operations	$433.43M
Consolidated Net Income/Loss	$433.43M
Normalized Income after Taxes	$437.71M
EBIT	$534.18M
EBITDA	$539.46M
Weighted-Average Shares Outstanding (Basic)	435.48M
Weighted-Average Shares Outstanding (Diluted)	578.10M
Earnings per Share (EPS) (Basic)	$0.55
Earnings per Share (EPS) (Diluted)	$0.55
Balance Sheet Financials
Current Assets	$1.84B
Property, Plant, and Equipment	$15.03B
Long-Term Assets	$15.77B
Total Assets	$17.61B
Current Liabilities	$1.18B
Long-Term Debt	$6.62B
Long-Term Liabilities	$6.64B
Total Liabilities	$7.82B
Common Equity	$9.79B
Tangible Shareholders Equity	$9.79B
Shareholders Equity	$9.79B
Common Shares Outstanding	961.02M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$596.08M
Cash Flow from Investing Activities	$503.92M
Cash Flow from Financial Activities	$-941.30M
Beginning Cash	$929.03M
End Cash	$1.09B
Increase/Decrease in Cash	$158.69M
Stock-Based Compensation	$0.52M
Common Stock Dividends Paid	$-233.81M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	1.56
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.40
Debt to Equity Ratio	0.78
Gross Margin	100.00%
Operating Margin	94.01%
EBIT Margin	94.01%
EBITDA Margin	--
Pre-Tax Profit Margin	76.28%
Profit Margin	41.94%
Free Cash Flow	$595.02M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.03
Inventory Turnover	--
Receiveable Turnover	23.89
Days Sales in Receivables	3.77
Return on Equity	4.43%
Return on Tangible Equity	4.43%
Return on Assets	2.46%
Return on Investments	2.64%
Book Value Per Share	$10.19
Free Cash Flow per Share	$1.03
Operating Cash Flow per Share	$1.03

Data from Zacks Investment Research, Inc.